Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumor-Agnostic Circulating Tumor DNA Analysis as a Comprehensive Predictive Biomarker of Recurrence after Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer

Clinical Lung Cancer(2025)10.1016/j.cllc.2025.09.013Source: DataRank Database

Tumor-Agnostic Circulating Tumor DNA Analysis as a Comprehensive Predictive Biomarker of Recurrence after Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer is a research paper published in Clinical Lung Cancer (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.47)OA: closedTopics (31)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Shun-Ichiro Kageyama,Hidenari Hirata ORCID,Masaki Ohira,Shunsuke A. Sakai ORCID,Yumi Hakozaki

Live enrichment

PubMed:41130887 OpenAlex:https://openalex.org/W4414694771

Japan Society for the Promotion of Science

Grant: 24K10926

Japan Society for the Promotion of Science

Grant: JP22H04925

Japan Society for the Promotion of Science

Grant: 21K07689

Japan Agency for Medical Research and Development

Grant: JP22ck0106581

Japan Agency for Medical Research and Development

Grant: JP24ck0106956

Yasuda Memorial Medical Foundation

Illumina

FWCI

0.47

Citation Percentile

0.7%

Citation Trend

2026

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S1525730425002384?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525730425002384?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cllc.2025.09.013

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41130887

Fields of Study

Cancer Genomics and DiagnosticsLung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

MeSH Terms

Circulating Tumor DNAAdultAgedAged, 80 and overCarcinoma, Non-Small-Cell LungFemaleFollow-Up StudiesHumansLung NeoplasmsMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingPrognosisRetrospective StudiesBiomarkers, TumorSurvival Rate

Keywords

Ablative caseLung cancerRadiation therapyCirculating tumor DNABiomarkerCirculating tumor cellRadiotherapyctDNANSCLCLiquid BiopsyTumor-agnostic

Tumor-Agnostic Circulating Tumor DNA Analysis as a Comprehensive Predictive Biomarker of Recurrence after Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer

FAIR Checklist

Authors (17)

Funding (7 grants)

Impact

Open Access

Topics